News
The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 /PRNewswire/ ...
Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening ...
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
4d
News Medical on MSNMassey becomes first U.S. site to enroll patients in global Phase 2a trial of first-in-class therapy for T-cell lymphomaVCU Massey Comprehensive Cancer Center is the first site in the United States to be activated in a global Phase 2a clinical ...
2d
Clinical Trials Arena on MSNCelcuity stock rallies on Phase III breast cancer trial progressShares in Celcuity climbed by 233.76% at market open on 28 July after it reported the Phase III breast cancer data.
Pioneering approach to halting the chronic neuroinflammation responsible for neurodegeneration- Trial to assess safety, PK and detect early signs of efficacy- Initial data expected in mid-2026 ...
Decentralized Clinical Trials (DCTs) are transforming how we collect clinical data, but this evolution brings unprecedented challenges in data quality, complexity, and integration.
TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich, has entered its first clinical trial in patients. Following a successful phase 1a ...
6d
IFLScience on MSN"Groundbreaking" Obesity Treatment That Turns Up The Heat On Fat Cells Passes Phase I Clinical TrialsThe new drug forces fat cells to produce more energy and doesn't impact appetite or muscle mass, unlike some existing ...
1h
The Kenya Times on MSN20,000 Kenyans Among Participants of Ksh72.5 Billion Vaccine TrialA new tuberculosis (TB) vaccine candidate, M72/AS01E, has entered Phase III clinical trials, with Kenyans among the 20,000 ...
Durham-based TruTechnologies has secured a strategic growth investment from LLR Partners to accelerate the expansion of its real-time clinical trial oversight solutions and fuel the next phase of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results